Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Celmatix Sues 23andMe for $100M Alleging Breach of Contract

Celmatix Sues 23andMe for $100M Alleging Breach of Contract

Dec 10, 2019
|
staff reporter

NEW YORK – Celmatix on Tuesday sued 23andMe for $100 million in New York State Supreme Court, accusing the consumer genomics firm of breach of agreement and of wilfully blocking its ability to raise capital.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Extension Call

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

All Along the Axon

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

For the Accelerator

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

Science Papers Describe New Cas9 Variant, Atlas of Human Metabolism

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

What's Popular?

In Business News

  1. Fosun Long March Gets Chinese Regulatory Approval for Coronavirus MDx Kit

  2. AusDiagnostics Gets CE Mark for Multiplex Coronavirus, Flu, RSV Assay

  3. Biocept More Than Doubles Q4 Revenues; Full-Year Revenues Grow 70 Percent

  4. Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test

  5. GigaMune Hopes to Offer TCR Screens to Pharmas While Scrambling to Keep Expression Libraries Alive

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.